Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: VMD (Veterinary Medicines Directorate)
Imidacloprid, Permethrin (Cis:Trans 40:60)
Krka d.d., Novo Mesto
QP53AC54
Imidacloprid, Permethrin (Cis:Trans 40:60)
Spot-on solution
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Ectoparasiticide
Authorized
2015-12-16
Revised: October 2021 AN: 01901/2020, 01967/2020, 00343/2021 & 00345/2021 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ataxxa 2000 mg/400 mg spot-on solution for dogs over 25 kg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4.0 ml pipette contains: ACTIVE SUBSTANCES: Permethrin 2000.0 mg Imidacloprid 400.0 mg EXCIPIENTS: Butylhydroxytoluene (E321) 4.0 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Spot-on solution. Clear yellowish to brownish solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and prevention of flea (_Ctenocephalides felis_) infestation. Fleas on dogs are killed within one day following treatment. One treatment prevents further flea infestation for four weeks. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). The product has persistent acaricidal efficacy against tick infestations (_Rhipicephalus _ _sanguineus_ and _Ixodes ricinus _ for four weeks, and _Dermacentor reticulatus _for three weeks) and persistent repellent efficacy (_Ixodes ricinus_) for three weeks. Ticks already on the dog may not be killed within two days after treatment and may remain attached and visible. Therefore the removal of ticks already on the dog at the time of treatment is recommended, in order to prevent them from attaching and having a blood meal. Revised: October 2021 AN: 01901/2020, 01967/2020, 00343/2021 & 00345/2021 Page 2 of 9 One treatment provides repellent (anti-feeding) activity against the sand fly _Phlebotomus perniciosus_ for three weeks and against the mosquito _Aedes aegypti_ from 7 days up to 14 days after treatment. 4.3 CONTRAINDICATIONS In the absence of available data do not use the product on puppies of less than 7 weeks of age, or 25 kg of weight. Do not use in known cases of hypersensitivity to the active substances or to any of the excipients. Do not use on cats. (Refer to section 4.5 – Special preca Belgenin tamamını okuyun